GB0912646D0 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
GB0912646D0
GB0912646D0 GBGB0912646.7A GB0912646A GB0912646D0 GB 0912646 D0 GB0912646 D0 GB 0912646D0 GB 0912646 A GB0912646 A GB 0912646A GB 0912646 D0 GB0912646 D0 GB 0912646D0
Authority
GB
United Kingdom
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0912646.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GBGB0912646.7A priority Critical patent/GB0912646D0/en
Publication of GB0912646D0 publication Critical patent/GB0912646D0/en
Priority to US13/384,388 priority patent/US8697755B2/en
Priority to JP2012521008A priority patent/JP6021641B2/ja
Priority to ES10731762.0T priority patent/ES2616322T3/es
Priority to EP10731762.0A priority patent/EP2456430B1/en
Priority to PCT/EP2010/060326 priority patent/WO2011009818A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0912646.7A 2009-07-21 2009-07-21 Improvements in or relating to organic compounds Ceased GB0912646D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0912646.7A GB0912646D0 (en) 2009-07-21 2009-07-21 Improvements in or relating to organic compounds
US13/384,388 US8697755B2 (en) 2009-07-21 2010-07-16 Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia
JP2012521008A JP6021641B2 (ja) 2009-07-21 2010-07-16 夜間低血糖症の治療にて用いるためのテルブタリンなどのベータ２アドレナリン作動性受容体アゴニスト
ES10731762.0T ES2616322T3 (es) 2009-07-21 2010-07-16 Forma farmacéutica oral de liberación modificada de terbutalina para su uso en el tratamiento de la hipoglucemia nocturna
EP10731762.0A EP2456430B1 (en) 2009-07-21 2010-07-16 Modified release oral dosage form of terbutaline for use in the treatment of nocturnal hypoglycemia
PCT/EP2010/060326 WO2011009818A1 (en) 2009-07-21 2010-07-16 Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0912646.7A GB0912646D0 (en) 2009-07-21 2009-07-21 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
GB0912646D0 true GB0912646D0 (en) 2009-08-26

Family

ID=41058278

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0912646.7A Ceased GB0912646D0 (en) 2009-07-21 2009-07-21 Improvements in or relating to organic compounds

Country Status (6)

Country Link
US (1) US8697755B2 (enExample)
EP (1) EP2456430B1 (enExample)
JP (1) JP6021641B2 (enExample)
ES (1) ES2616322T3 (enExample)
GB (1) GB0912646D0 (enExample)
WO (1) WO2011009818A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
GB201218012D0 (en) * 2012-10-08 2012-11-21 Jagotec Ag Dosage forms
EP3865120B1 (en) 2013-07-19 2025-06-25 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
WO2015082389A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19809719A1 (de) * 1998-03-06 1999-09-09 Roehm Gmbh Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
EP2319585A1 (en) * 2002-08-29 2011-05-11 Cipla Ltd. Pharmaceutical products and compositions comprising salmeterol, fluticasone and ipratropium or tiotropium

Also Published As

Publication number Publication date
WO2011009818A1 (en) 2011-01-27
EP2456430A1 (en) 2012-05-30
ES2616322T3 (es) 2017-06-12
US8697755B2 (en) 2014-04-15
JP2012533595A (ja) 2012-12-27
EP2456430B1 (en) 2016-10-19
JP6021641B2 (ja) 2016-11-09
US20120196938A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
GB0816880D0 (en) Improvements in or relating to organic compounds
GB0708141D0 (en) Improvements in or relating to organic compounds
GB0811335D0 (en) Improvements in or relating to amphibians
AP2713A (en) Improvements in or relating to organic compounds
GB0802457D0 (en) Improvements in or relating to stairlifts
GB201002612D0 (en) Improvements in or relating to organic compounds
GB0912646D0 (en) Improvements in or relating to organic compounds
GB2463734B (en) Improvements in or relating to stairlifts
GB0804752D0 (en) Improvements in or relating to wall-ties
EG26192A (en) Improvements in organic or related compounds
GB0810840D0 (en) Improvements in or relating to stairlifts
GB0905657D0 (en) Improvements in or relating to stairlifts
GB0714790D0 (en) Improvements in or relating to organic compounds
GB2457767B (en) Improvements in or relating to stairlifts
GB0814296D0 (en) Improvements to coffins
GB201118182D0 (en) Improvements in or relating to organic compounds
GB0709886D0 (en) Improvements in or relating to organic compounds
GB0909994D0 (en) Improvements in or relating to stairlifts
GB2488051B (en) Improvements in or relating to stairlifts
GB201118198D0 (en) Improvements in or relating to organic compounds
GB201109214D0 (en) Improvements in or relating to organic compounds
GB0901712D0 (en) Improvements in or relating to organic compounds
GB0921601D0 (en) Improvements in or relating to organic compounds
GB0915943D0 (en) Improvements in or relating to organic compounds
GB0915795D0 (en) Improvements in or relatiing to organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)